Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice
Related Experiment Video
Updated: Feb 9, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Luca De Nicola1, Luca Di Lullo2, Ernesto Paoletti3
1Division of Nephrology, University of Campania, Piazza L. Miraglia, 1, 80138, Naples, Italy. luca.denicola@unicampania.it.
Insights
Managing chronic hyperkalemia in chronic kidney disease (CKD) remains challenging, with current treatments often suboptimal. This review addresses unresolved issues in CKD hyperkalemia management, exploring diagnosis, comorbidities, and therapies.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Pharmacology
Background:
- Chronic hyperkalemia is a frequent complication of chronic kidney disease (CKD), associated with poor prognosis.
- Current management strategies for hyperkalemia in CKD patients are often suboptimal, despite optimal care settings.
- Hyperkalemia necessitates careful management by nephrologists due to its prevalence and impact.
Purpose of the Study:
- To identify and discuss unresolved issues in the management of chronic hyperkalemia in non-dialysis CKD patients.
- To provide opinion-based answers on controversial topics concerning hyperkalemia in CKD.
- To review current diagnostic and therapeutic approaches and explore new treatment options.
Main Methods:
- Literature review and synthesis of current evidence.
- Discussion of clinical topics including diagnosis and comorbidities.
- Evaluation of current and emerging therapeutic strategies, including dietary and pharmacological treatments.
Main Results:
- Unresolved issues in diagnosis and the relationship between hyperkalemia and CKD comorbidities were identified.
- The efficacy of current dietary and pharmacological treatments for hyperkalemia was critically assessed.
- The potential role of novel potassium binders in managing hyperkalemia was explored.
Conclusions:
- Effective management of chronic hyperkalemia in non-dialysis CKD requires addressing several unresolved clinical issues.
- Further research and optimized therapeutic strategies are needed to improve hyperkalemia control in CKD.
- Newer potassium binders may offer promising solutions for managing this complex complication.
Abstract:
Chronic hyperkalemia is a major complication of chronic kidney disease (CKD) that occurs frequently, heralds poor prognosis, and necessitates careful management by the nephrologist. Current strategies aimed at prevention and treatment of hyperkalemia are still suboptimal, as evidenced by the relatively high prevalence of hyperkalemia in patients under stable nephrology care, and even in the ideal setting of randomized trials where best treatment and monitoring are mandatory. The aim of this review was to identify and discuss a range of unresolved issues related to the management of chronic hyperkalemia in non-dialysis CKD. The following topics of clinical interest were addressed: diagnosis, relationship with main comorbidities of CKD, therapy with inhibitors of the renin-angiotensin-aldosterone system, efficacy of current dietary and pharmacological treatment, and the potential role of the new generation of potassium binders. Opinion-based answers are provided for each of these controversial issues.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Ethical Issues
Ethical Concerns in Healthcare:
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Peritoneal Dialysis I: Introduction and Procedure

